BioCentury
ARTICLE | Company News

Biocartis raises EUR 64.5M, spins out newco

September 5, 2014 1:54 AM UTC

Biocartis S.A. (Lausanne, Switzerland) raised EUR 64.5 million ($84.7 million) in an undisclosed venture round and separately spun out a newco, MyCartis, to develop the multiplex assay technology of Biocartis' Evalution business unit.

The funding came from Biocartis' existing investors Johnson & Johnson Development Corp., the venture arm of Johnson & Johnson (NYSE:JNJ); and PMV Tina Fund and new investor Hitachi Chemical Co. Ltd. (Tokyo:4217). Undisclosed new and existing individual investors also participated (see BioCentury, Nov. 18, 2013). ...